News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bristol-Myers Squibb Company (BMY) Coupons for Abilify are Not Bribes: Judge



6/5/2013 7:38:00 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

For the second time in recent weeks, a federal judge has dismissed lawsuits filed by unions that claimed the coupons issued by drugmakers interfered with their health plans and violated racketeering and anti-trust laws by masquerading as bribes and kickbacks. The latest victory went to Bristol-Myers Squibb, which was charged with defrauding the union health plans by offering discounts directly to consumers in a bid to preserve market share for its Abilify anti-psychotic. In April, a similar case against Merck (MRK) was dismissed by a different federal Judge. In a 35-page decision, US District Court Judge Paul Oetken rejected all of the arguments made by the unions – the American Federation of State, County and Municipal Employees District Council 37 and Sergeants Benevolent Association – but would allow them to refile their suits concerning charges that the drugmaker allegedly misreported industry benchmark prices.

Help employers find you! Check out all the jobs and post your resume.

Read at Pharmalot
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES